nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—respiratory system—lung cancer	0.028	0.127	CbGeAlD
Tiludronate—ATP6V1A—mammary gland—lung cancer	0.0252	0.114	CbGeAlD
Tiludronate—PTPN1—Lapatinib—Gefitinib—lung cancer	0.0249	1	CbGdCrCtD
Tiludronate—PTPN1—bronchus—lung cancer	0.0231	0.104	CbGeAlD
Tiludronate—PTPN1—trachea—lung cancer	0.0207	0.0937	CbGeAlD
Tiludronate—PTPN1—cardiac atrium—lung cancer	0.0195	0.088	CbGeAlD
Tiludronate—ATP6V1A—respiratory system—lung cancer	0.0168	0.076	CbGeAlD
Tiludronate—PTPN1—lung—lung cancer	0.0149	0.0673	CbGeAlD
Tiludronate—ATP6V1A—bronchus—lung cancer	0.0138	0.0625	CbGeAlD
Tiludronate—ATP6V1A—trachea—lung cancer	0.0124	0.0561	CbGeAlD
Tiludronate—ATP6V1A—cardiac atrium—lung cancer	0.0117	0.0527	CbGeAlD
Tiludronate—PTPN1—lymph node—lung cancer	0.0102	0.046	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—lung cancer	0.00985	0.0445	CbGeAlD
Tiludronate—ATP6V1A—lung—lung cancer	0.00892	0.0403	CbGeAlD
Tiludronate—ATP6V1A—lymph node—lung cancer	0.0061	0.0276	CbGeAlD
Tiludronate—Bone pain—Vinblastine—lung cancer	0.00551	0.0211	CcSEcCtD
Tiludronate—Bone pain—Topotecan—lung cancer	0.00535	0.0205	CcSEcCtD
Tiludronate—Bone pain—Erlotinib—lung cancer	0.0053	0.0203	CcSEcCtD
Tiludronate—Influenza-like symptoms—Gemcitabine—lung cancer	0.00493	0.0189	CcSEcCtD
Tiludronate—Influenza-like symptoms—Paclitaxel—lung cancer	0.00413	0.0158	CcSEcCtD
Tiludronate—Bone pain—Gemcitabine—lung cancer	0.00368	0.0141	CcSEcCtD
Tiludronate—Influenza like illness—Gemcitabine—lung cancer	0.00342	0.0131	CcSEcCtD
Tiludronate—Myalgia—Pemetrexed—lung cancer	0.00318	0.0122	CcSEcCtD
Tiludronate—Arthralgia—Pemetrexed—lung cancer	0.00318	0.0122	CcSEcCtD
Tiludronate—Bone pain—Paclitaxel—lung cancer	0.00308	0.0118	CcSEcCtD
Tiludronate—Dyspepsia—Crizotinib—lung cancer	0.00294	0.0113	CcSEcCtD
Tiludronate—Influenza like illness—Paclitaxel—lung cancer	0.00287	0.011	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00278	0.0107	CcSEcCtD
Tiludronate—Dyspepsia—Pemetrexed—lung cancer	0.00268	0.0103	CcSEcCtD
Tiludronate—Bone pain—Docetaxel—lung cancer	0.00261	0.01	CcSEcCtD
Tiludronate—Pain—Pemetrexed—lung cancer	0.00261	0.01	CcSEcCtD
Tiludronate—Pain—Gefitinib—lung cancer	0.00259	0.00993	CcSEcCtD
Tiludronate—Rhinitis—Topotecan—lung cancer	0.00258	0.0099	CcSEcCtD
Tiludronate—Gastrointestinal pain—Pemetrexed—lung cancer	0.00249	0.00956	CcSEcCtD
Tiludronate—Gastrointestinal pain—Gefitinib—lung cancer	0.00248	0.0095	CcSEcCtD
Tiludronate—Influenza like illness—Docetaxel—lung cancer	0.00243	0.00932	CcSEcCtD
Tiludronate—Abdominal pain—Pemetrexed—lung cancer	0.00241	0.00924	CcSEcCtD
Tiludronate—Abdominal pain—Gefitinib—lung cancer	0.00239	0.00918	CcSEcCtD
Tiludronate—Asthenia—Crizotinib—lung cancer	0.00239	0.00918	CcSEcCtD
Tiludronate—Diarrhoea—Crizotinib—lung cancer	0.00228	0.00875	CcSEcCtD
Tiludronate—Dizziness—Crizotinib—lung cancer	0.00221	0.00846	CcSEcCtD
Tiludronate—Asthenia—Pemetrexed—lung cancer	0.00219	0.00839	CcSEcCtD
Tiludronate—Asthenia—Gefitinib—lung cancer	0.00217	0.00833	CcSEcCtD
Tiludronate—Back pain—Topotecan—lung cancer	0.00217	0.00832	CcSEcCtD
Tiludronate—Back pain—Erlotinib—lung cancer	0.00215	0.00823	CcSEcCtD
Tiludronate—Diarrhoea—Pemetrexed—lung cancer	0.00209	0.008	CcSEcCtD
Tiludronate—Vertigo—Vinblastine—lung cancer	0.00207	0.00795	CcSEcCtD
Tiludronate—Diarrhoea—Gefitinib—lung cancer	0.00207	0.00795	CcSEcCtD
Tiludronate—Gastrointestinal pain—Teniposide—lung cancer	0.00202	0.00774	CcSEcCtD
Tiludronate—Dizziness—Pemetrexed—lung cancer	0.00202	0.00773	CcSEcCtD
Tiludronate—Nausea—Crizotinib—lung cancer	0.00198	0.0076	CcSEcCtD
Tiludronate—Abdominal pain—Teniposide—lung cancer	0.00195	0.00749	CcSEcCtD
Tiludronate—Arthralgia—Topotecan—lung cancer	0.00191	0.00732	CcSEcCtD
Tiludronate—Myalgia—Topotecan—lung cancer	0.00191	0.00732	CcSEcCtD
Tiludronate—Arthralgia—Erlotinib—lung cancer	0.00189	0.00724	CcSEcCtD
Tiludronate—Myalgia—Erlotinib—lung cancer	0.00189	0.00724	CcSEcCtD
Tiludronate—Back pain—Vinorelbine—lung cancer	0.00185	0.00712	CcSEcCtD
Tiludronate—Rhinitis—Irinotecan—lung cancer	0.00182	0.00699	CcSEcCtD
Tiludronate—Nausea—Pemetrexed—lung cancer	0.00181	0.00694	CcSEcCtD
Tiludronate—Nausea—Gefitinib—lung cancer	0.0018	0.0069	CcSEcCtD
Tiludronate—Rhinitis—Gemcitabine—lung cancer	0.00177	0.00681	CcSEcCtD
Tiludronate—Asthenia—Teniposide—lung cancer	0.00177	0.00679	CcSEcCtD
Tiludronate—Vertigo—Vinorelbine—lung cancer	0.00172	0.00661	CcSEcCtD
Tiludronate—Diarrhoea—Teniposide—lung cancer	0.00169	0.00648	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Topotecan—lung cancer	0.00167	0.00639	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00165	0.00633	CcSEcCtD
Tiludronate—Myalgia—Vinorelbine—lung cancer	0.00163	0.00626	CcSEcCtD
Tiludronate—Arthralgia—Vinorelbine—lung cancer	0.00163	0.00626	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—lung cancer	0.00163	0.00625	CcSEcCtD
Tiludronate—Pain—Vinblastine—lung cancer	0.00161	0.00618	CcSEcCtD
Tiludronate—Dyspepsia—Topotecan—lung cancer	0.00161	0.00618	CcSEcCtD
Tiludronate—Dyspepsia—Erlotinib—lung cancer	0.00159	0.00611	CcSEcCtD
Tiludronate—Pain—Topotecan—lung cancer	0.00156	0.006	CcSEcCtD
Tiludronate—Pain—Erlotinib—lung cancer	0.00155	0.00594	CcSEcCtD
Tiludronate—Headache—Teniposide—lung cancer	0.00155	0.00593	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vinblastine—lung cancer	0.00154	0.00591	CcSEcCtD
Tiludronate—Back pain—Irinotecan—lung cancer	0.00153	0.00587	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—lung cancer	0.00152	0.00581	CcSEcCtD
Tiludronate—Gastrointestinal pain—Topotecan—lung cancer	0.0015	0.00574	CcSEcCtD
Tiludronate—Back pain—Gemcitabine—lung cancer	0.00149	0.00572	CcSEcCtD
Tiludronate—Abdominal pain—Vinblastine—lung cancer	0.00149	0.00571	CcSEcCtD
Tiludronate—Rhinitis—Paclitaxel—lung cancer	0.00149	0.0057	CcSEcCtD
Tiludronate—Gastrointestinal pain—Erlotinib—lung cancer	0.00148	0.00568	CcSEcCtD
Tiludronate—Nausea—Teniposide—lung cancer	0.00147	0.00562	CcSEcCtD
Tiludronate—Abdominal pain—Topotecan—lung cancer	0.00145	0.00555	CcSEcCtD
Tiludronate—Abdominal pain—Erlotinib—lung cancer	0.00143	0.00549	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00143	0.00547	CcSEcCtD
Tiludronate—Vertigo—Irinotecan—lung cancer	0.00142	0.00545	CcSEcCtD
Tiludronate—Asthenia—Vinblastine—lung cancer	0.00135	0.00518	CcSEcCtD
Tiludronate—Pain—Vinorelbine—lung cancer	0.00134	0.00513	CcSEcCtD
Tiludronate—Asthenia—Topotecan—lung cancer	0.00131	0.00504	CcSEcCtD
Tiludronate—Arthralgia—Gemcitabine—lung cancer	0.00131	0.00503	CcSEcCtD
Tiludronate—Myalgia—Gemcitabine—lung cancer	0.00131	0.00503	CcSEcCtD
Tiludronate—Asthenia—Erlotinib—lung cancer	0.0013	0.00498	CcSEcCtD
Tiludronate—Diarrhoea—Vinblastine—lung cancer	0.00129	0.00494	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vinorelbine—lung cancer	0.00128	0.00491	CcSEcCtD
Tiludronate—Back pain—Etoposide—lung cancer	0.00127	0.00488	CcSEcCtD
Tiludronate—Rhinitis—Docetaxel—lung cancer	0.00126	0.00483	CcSEcCtD
Tiludronate—Diarrhoea—Topotecan—lung cancer	0.00125	0.0048	CcSEcCtD
Tiludronate—Back pain—Paclitaxel—lung cancer	0.00125	0.00479	CcSEcCtD
Tiludronate—Dizziness—Vinblastine—lung cancer	0.00125	0.00478	CcSEcCtD
Tiludronate—Diarrhoea—Erlotinib—lung cancer	0.00124	0.00475	CcSEcCtD
Tiludronate—Abdominal pain—Vinorelbine—lung cancer	0.00124	0.00475	CcSEcCtD
Tiludronate—Myalgia—Cisplatin—lung cancer	0.00122	0.00469	CcSEcCtD
Tiludronate—Dizziness—Topotecan—lung cancer	0.00121	0.00464	CcSEcCtD
Tiludronate—Dizziness—Erlotinib—lung cancer	0.0012	0.00459	CcSEcCtD
Tiludronate—Vertigo—Etoposide—lung cancer	0.00118	0.00453	CcSEcCtD
Tiludronate—Headache—Vinblastine—lung cancer	0.00118	0.00453	CcSEcCtD
Tiludronate—Vertigo—Paclitaxel—lung cancer	0.00116	0.00445	CcSEcCtD
Tiludronate—Headache—Topotecan—lung cancer	0.00115	0.0044	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00115	0.00439	CcSEcCtD
Tiludronate—Dyspepsia—Irinotecan—lung cancer	0.00114	0.00436	CcSEcCtD
Tiludronate—Headache—Erlotinib—lung cancer	0.00113	0.00435	CcSEcCtD
Tiludronate—Asthenia—Vinorelbine—lung cancer	0.00112	0.00431	CcSEcCtD
Tiludronate—Nausea—Vinblastine—lung cancer	0.00112	0.00429	CcSEcCtD
Tiludronate—Pain—Irinotecan—lung cancer	0.0011	0.00423	CcSEcCtD
Tiludronate—Arthralgia—Paclitaxel—lung cancer	0.0011	0.00421	CcSEcCtD
Tiludronate—Myalgia—Paclitaxel—lung cancer	0.0011	0.00421	CcSEcCtD
Tiludronate—Nausea—Topotecan—lung cancer	0.00109	0.00417	CcSEcCtD
Tiludronate—Pain—Gemcitabine—lung cancer	0.00108	0.00412	CcSEcCtD
Tiludronate—Nausea—Erlotinib—lung cancer	0.00108	0.00412	CcSEcCtD
Tiludronate—Diarrhoea—Vinorelbine—lung cancer	0.00107	0.00411	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00107	0.0041	CcSEcCtD
Tiludronate—Back pain—Docetaxel—lung cancer	0.00106	0.00406	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irinotecan—lung cancer	0.00106	0.00405	CcSEcCtD
Tiludronate—Dizziness—Vinorelbine—lung cancer	0.00103	0.00397	CcSEcCtD
Tiludronate—Abdominal pain—Irinotecan—lung cancer	0.00102	0.00391	CcSEcCtD
Tiludronate—Pain—Cisplatin—lung cancer	0.001	0.00384	CcSEcCtD
Tiludronate—Headache—Vinorelbine—lung cancer	0.00098	0.00376	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000959	0.00368	CcSEcCtD
Tiludronate—Arthralgia—Docetaxel—lung cancer	0.000931	0.00357	CcSEcCtD
Tiludronate—Myalgia—Docetaxel—lung cancer	0.000931	0.00357	CcSEcCtD
Tiludronate—Nausea—Vinorelbine—lung cancer	0.00093	0.00357	CcSEcCtD
Tiludronate—Dyspepsia—Paclitaxel—lung cancer	0.000927	0.00355	CcSEcCtD
Tiludronate—Asthenia—Irinotecan—lung cancer	0.000926	0.00355	CcSEcCtD
Tiludronate—Pain—Etoposide—lung cancer	0.000918	0.00352	CcSEcCtD
Tiludronate—Asthenia—Gemcitabine—lung cancer	0.000902	0.00346	CcSEcCtD
Tiludronate—Pain—Paclitaxel—lung cancer	0.0009	0.00345	CcSEcCtD
Tiludronate—Diarrhoea—Irinotecan—lung cancer	0.000883	0.00339	CcSEcCtD
Tiludronate—Gastrointestinal pain—Etoposide—lung cancer	0.000878	0.00337	CcSEcCtD
Tiludronate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000861	0.0033	CcSEcCtD
Tiludronate—Diarrhoea—Gemcitabine—lung cancer	0.00086	0.0033	CcSEcCtD
Tiludronate—Dizziness—Irinotecan—lung cancer	0.000854	0.00327	CcSEcCtD
Tiludronate—Abdominal pain—Etoposide—lung cancer	0.000849	0.00326	CcSEcCtD
Tiludronate—Asthenia—Cisplatin—lung cancer	0.000841	0.00323	CcSEcCtD
Tiludronate—Abdominal pain—Paclitaxel—lung cancer	0.000832	0.00319	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000813	0.00312	CcSEcCtD
Tiludronate—Headache—Irinotecan—lung cancer	0.000809	0.0031	CcSEcCtD
Tiludronate—Diarrhoea—Cisplatin—lung cancer	0.000802	0.00308	CcSEcCtD
Tiludronate—Headache—Gemcitabine—lung cancer	0.000788	0.00302	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—lung cancer	0.000786	0.00301	CcSEcCtD
Tiludronate—Dyspepsia—Docetaxel—lung cancer	0.000785	0.00301	CcSEcCtD
Tiludronate—Asthenia—Etoposide—lung cancer	0.00077	0.00296	CcSEcCtD
Tiludronate—Nausea—Irinotecan—lung cancer	0.000767	0.00294	CcSEcCtD
Tiludronate—Pain—Docetaxel—lung cancer	0.000763	0.00293	CcSEcCtD
Tiludronate—Back pain—Methotrexate—lung cancer	0.000762	0.00292	CcSEcCtD
Tiludronate—Asthenia—Paclitaxel—lung cancer	0.000755	0.0029	CcSEcCtD
Tiludronate—Nausea—Gemcitabine—lung cancer	0.000747	0.00286	CcSEcCtD
Tiludronate—Diarrhoea—Etoposide—lung cancer	0.000735	0.00282	CcSEcCtD
Tiludronate—Gastrointestinal pain—Docetaxel—lung cancer	0.00073	0.0028	CcSEcCtD
Tiludronate—Diarrhoea—Paclitaxel—lung cancer	0.00072	0.00276	CcSEcCtD
Tiludronate—Dizziness—Etoposide—lung cancer	0.00071	0.00272	CcSEcCtD
Tiludronate—Vertigo—Methotrexate—lung cancer	0.000708	0.00272	CcSEcCtD
Tiludronate—Abdominal pain—Docetaxel—lung cancer	0.000705	0.00271	CcSEcCtD
Tiludronate—Dizziness—Paclitaxel—lung cancer	0.000696	0.00267	CcSEcCtD
Tiludronate—Nausea—Cisplatin—lung cancer	0.000696	0.00267	CcSEcCtD
Tiludronate—Headache—Etoposide—lung cancer	0.000673	0.00258	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—lung cancer	0.000671	0.00257	CcSEcCtD
Tiludronate—Arthralgia—Methotrexate—lung cancer	0.000671	0.00257	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—lung cancer	0.00066	0.00253	CcSEcCtD
Tiludronate—Headache—Paclitaxel—lung cancer	0.000659	0.00253	CcSEcCtD
Tiludronate—Asthenia—Docetaxel—lung cancer	0.00064	0.00246	CcSEcCtD
Tiludronate—Nausea—Etoposide—lung cancer	0.000638	0.00245	CcSEcCtD
Tiludronate—Nausea—Paclitaxel—lung cancer	0.000625	0.0024	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—lung cancer	0.000613	0.00235	CcSEcCtD
Tiludronate—Diarrhoea—Docetaxel—lung cancer	0.000611	0.00234	CcSEcCtD
Tiludronate—Dizziness—Docetaxel—lung cancer	0.00059	0.00226	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000586	0.00225	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—lung cancer	0.000581	0.00223	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—lung cancer	0.000581	0.00223	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—lung cancer	0.000566	0.00217	CcSEcCtD
Tiludronate—Headache—Docetaxel—lung cancer	0.000559	0.00214	CcSEcCtD
Tiludronate—Pain—Methotrexate—lung cancer	0.00055	0.00211	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—GRM8—lung cancer	0.000531	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GRM8—lung cancer	0.000531	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—lung cancer	0.00053	0.00107	CbGpPWpGaD
Tiludronate—Nausea—Docetaxel—lung cancer	0.00053	0.00203	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methotrexate—lung cancer	0.000526	0.00202	CcSEcCtD
Tiludronate—ATP6V1A—Disease—ADCY1—lung cancer	0.000525	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRF1—lung cancer	0.000518	0.00105	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ENO2—lung cancer	0.000515	0.00104	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SKI—lung cancer	0.000514	0.00104	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SKI—lung cancer	0.000514	0.00104	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PPP2R1B—lung cancer	0.000512	0.00104	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SMARCA4—lung cancer	0.000512	0.00104	CbGpPWpGaD
Tiludronate—Abdominal pain—Methotrexate—lung cancer	0.000508	0.00195	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000507	0.00195	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—lung cancer	0.00049	0.00188	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—PIK3CG—lung cancer	0.000488	0.00099	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—EGF—lung cancer	0.000483	0.000979	CbGpPWpGaD
Tiludronate—Pain—Doxorubicin—lung cancer	0.000476	0.00183	CcSEcCtD
Tiludronate—PTPN1—Immune System—APP—lung cancer	0.000472	0.000956	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ENO1—lung cancer	0.000468	0.00095	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—AKT1—lung cancer	0.000468	0.000949	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGF9—lung cancer	0.000468	0.000948	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—lung cancer	0.000464	0.000941	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NRAS—lung cancer	0.000463	0.000939	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—lung cancer	0.000463	0.000939	CbGpPWpGaD
Tiludronate—Asthenia—Methotrexate—lung cancer	0.000461	0.00177	CcSEcCtD
Tiludronate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000455	0.00175	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—CREBBP—lung cancer	0.000453	0.000918	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PXN—lung cancer	0.000446	0.000905	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PXN—lung cancer	0.000446	0.000905	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MAPK3—lung cancer	0.000443	0.000899	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	0.000442	0.000897	CbGpPWpGaD
Tiludronate—Abdominal pain—Doxorubicin—lung cancer	0.00044	0.00169	CcSEcCtD
Tiludronate—Diarrhoea—Methotrexate—lung cancer	0.00044	0.00169	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—AKR1C1—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—OXTR—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GRP—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GRP—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKR1C1—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—OXTR—lung cancer	0.000437	0.000886	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APP—lung cancer	0.000435	0.000883	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGF9—lung cancer	0.000432	0.000876	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CD—lung cancer	0.000429	0.00087	CbGpPWpGaD
Tiludronate—Dizziness—Methotrexate—lung cancer	0.000425	0.00163	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—ALB—lung cancer	0.000424	0.000859	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JUNB—lung cancer	0.000412	0.000836	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GNG11—lung cancer	0.000409	0.00083	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GNG11—lung cancer	0.000409	0.00083	CbGpPWpGaD
Tiludronate—Headache—Methotrexate—lung cancer	0.000403	0.00155	CcSEcCtD
Tiludronate—Asthenia—Doxorubicin—lung cancer	0.0004	0.00153	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—lung cancer	0.000399	0.000808	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000392	0.000795	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FOXO3—lung cancer	0.000391	0.000793	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFC—lung cancer	0.00039	0.00079	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFC—lung cancer	0.00039	0.00079	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—RAF1—lung cancer	0.000383	0.000777	CbGpPWpGaD
Tiludronate—Nausea—Methotrexate—lung cancer	0.000382	0.00147	CcSEcCtD
Tiludronate—Diarrhoea—Doxorubicin—lung cancer	0.000381	0.00146	CcSEcCtD
Tiludronate—PTPN1—Immune System—ITGB1—lung cancer	0.000377	0.000764	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CB—lung cancer	0.000374	0.000759	CbGpPWpGaD
Tiludronate—Dizziness—Doxorubicin—lung cancer	0.000368	0.00141	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—ADCY1—lung cancer	0.000368	0.000746	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADCY1—lung cancer	0.000368	0.000746	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—lung cancer	0.000367	0.000744	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—lung cancer	0.000366	0.000742	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—lung cancer	0.000361	0.000733	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FOXO3—lung cancer	0.000361	0.000733	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPP2R1B—lung cancer	0.000359	0.000727	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SMARCA4—lung cancer	0.000359	0.000727	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPP2R1B—lung cancer	0.000359	0.000727	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SMARCA4—lung cancer	0.000359	0.000727	CbGpPWpGaD
Tiludronate—Headache—Doxorubicin—lung cancer	0.000349	0.00134	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—HSPB1—lung cancer	0.000346	0.000701	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HSPB1—lung cancer	0.000346	0.000701	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IL2—lung cancer	0.000344	0.000697	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTHLH—lung cancer	0.000342	0.000694	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTHLH—lung cancer	0.000342	0.000694	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD8A—lung cancer	0.000341	0.000691	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—lung cancer	0.000339	0.000687	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—RAF1—lung cancer	0.000332	0.000673	CbGpPWpGaD
Tiludronate—Nausea—Doxorubicin—lung cancer	0.000331	0.00127	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—lung cancer	0.000324	0.000657	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ANXA1—lung cancer	0.000322	0.000652	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ANXA1—lung cancer	0.000322	0.000652	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HES1—lung cancer	0.00032	0.000649	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB3—lung cancer	0.000317	0.000643	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FLT1—lung cancer	0.000311	0.000632	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FLT1—lung cancer	0.000311	0.000632	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—EP300—lung cancer	0.000308	0.000625	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH3—lung cancer	0.000305	0.000618	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APP—lung cancer	0.000305	0.000618	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APP—lung cancer	0.000305	0.000618	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH3—lung cancer	0.000305	0.000618	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF9—lung cancer	0.000302	0.000613	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF9—lung cancer	0.000302	0.000613	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—lung cancer	0.0003	0.000608	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERCC2—lung cancer	0.000299	0.000607	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGFR1—lung cancer	0.000295	0.000598	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB3—lung cancer	0.000293	0.000594	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—lung cancer	0.000292	0.000592	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—lung cancer	0.000292	0.000591	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUNB—lung cancer	0.000289	0.000585	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUNB—lung cancer	0.000289	0.000585	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NRAS—lung cancer	0.000288	0.000585	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—lung cancer	0.000281	0.000569	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK3—lung cancer	0.000276	0.00056	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR1—lung cancer	0.000272	0.000552	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HIF1A—lung cancer	0.000268	0.000544	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STK11—lung cancer	0.000262	0.000532	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STK11—lung cancer	0.000262	0.000532	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA1—lung cancer	0.000259	0.000525	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KIT—lung cancer	0.000256	0.000519	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGF—lung cancer	0.000253	0.000513	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FOXO3—lung cancer	0.000253	0.000513	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FOXO3—lung cancer	0.000253	0.000513	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—lung cancer	0.000248	0.000503	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP8—lung cancer	0.000238	0.000483	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6R—lung cancer	0.000238	0.000482	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CREBBP—lung cancer	0.000237	0.000481	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AVP—lung cancer	0.000237	0.000481	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AVP—lung cancer	0.000237	0.000481	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APC—lung cancer	0.000236	0.000479	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KIT—lung cancer	0.000236	0.000479	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—lung cancer	0.000236	0.000478	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGF—lung cancer	0.000234	0.000474	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1R—lung cancer	0.000228	0.000463	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1R—lung cancer	0.000228	0.000463	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—lung cancer	0.000228	0.000462	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAP2K1—lung cancer	0.000227	0.000459	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—lung cancer	0.000225	0.000456	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HES1—lung cancer	0.000224	0.000455	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HES1—lung cancer	0.000224	0.000455	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—lung cancer	0.000222	0.00045	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—lung cancer	0.000221	0.000447	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6R—lung cancer	0.000219	0.000445	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CREBBP—lung cancer	0.000219	0.000444	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—lung cancer	0.000211	0.000428	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAP2K1—lung cancer	0.000209	0.000424	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—lung cancer	0.000208	0.000421	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB3—lung cancer	0.000205	0.000416	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB3—lung cancer	0.000205	0.000416	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MDM2—lung cancer	0.000202	0.000409	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RAF1—lung cancer	0.000201	0.000407	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB2—lung cancer	0.000199	0.000403	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—lung cancer	0.000196	0.000398	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—lung cancer	0.000196	0.000398	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MTOR—lung cancer	0.000196	0.000398	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—lung cancer	0.000196	0.000398	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD4—lung cancer	0.000196	0.000397	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR1—lung cancer	0.000191	0.000387	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR1—lung cancer	0.000191	0.000387	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—lung cancer	0.000188	0.000381	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—lung cancer	0.000188	0.000381	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—lung cancer	0.000186	0.000378	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MDM2—lung cancer	0.000186	0.000377	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RAF1—lung cancer	0.000186	0.000376	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB2—lung cancer	0.000184	0.000372	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA1—lung cancer	0.000181	0.000368	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA1—lung cancer	0.000181	0.000368	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—lung cancer	0.000181	0.000367	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTOR—lung cancer	0.000181	0.000367	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD4—lung cancer	0.000181	0.000367	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—lung cancer	0.00018	0.000365	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—lung cancer	0.00018	0.000364	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—lung cancer	0.00018	0.000364	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—lung cancer	0.000179	0.000364	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JUN—lung cancer	0.000175	0.000355	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—lung cancer	0.00017	0.000344	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—lung cancer	0.00017	0.000344	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KIT—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KIT—lung cancer	0.000166	0.000336	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGF—lung cancer	0.000164	0.000332	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGF—lung cancer	0.000164	0.000332	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EP300—lung cancer	0.000162	0.000328	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—POMC—lung cancer	0.000158	0.000319	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—POMC—lung cancer	0.000158	0.000319	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—lung cancer	0.000157	0.000319	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—lung cancer	0.000157	0.000318	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—lung cancer	0.000157	0.000317	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—lung cancer	0.000156	0.000315	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—lung cancer	0.000156	0.000315	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6R—lung cancer	0.000154	0.000312	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6R—lung cancer	0.000154	0.000312	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CREBBP—lung cancer	0.000153	0.000311	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CREBBP—lung cancer	0.000153	0.000311	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—lung cancer	0.000152	0.000307	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NRAS—lung cancer	0.000151	0.000307	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EP300—lung cancer	0.000149	0.000303	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAP2K1—lung cancer	0.000146	0.000297	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAP2K1—lung cancer	0.000146	0.000297	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—lung cancer	0.000146	0.000295	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—lung cancer	0.000146	0.000295	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—lung cancer	0.000145	0.000294	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK3—lung cancer	0.000145	0.000294	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—lung cancer	0.00014	0.000284	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRAS—lung cancer	0.00014	0.000283	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—lung cancer	0.000138	0.000279	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK3—lung cancer	0.000134	0.000271	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MDM2—lung cancer	0.00013	0.000264	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MDM2—lung cancer	0.00013	0.000264	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—lung cancer	0.00013	0.000264	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—lung cancer	0.00013	0.000264	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RAF1—lung cancer	0.00013	0.000263	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RAF1—lung cancer	0.00013	0.000263	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB2—lung cancer	0.000129	0.000261	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB2—lung cancer	0.000129	0.000261	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—lung cancer	0.000127	0.000258	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MTOR—lung cancer	0.000127	0.000257	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—lung cancer	0.000127	0.000257	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MTOR—lung cancer	0.000127	0.000257	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—lung cancer	0.000127	0.000257	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—lung cancer	0.000122	0.000247	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—lung cancer	0.000122	0.000247	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—lung cancer	0.00012	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—lung cancer	0.00012	0.000242	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—lung cancer	0.000117	0.000237	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—lung cancer	0.000117	0.000237	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—lung cancer	0.000116	0.000236	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—lung cancer	0.000116	0.000236	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—lung cancer	0.000114	0.00023	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—lung cancer	0.000114	0.00023	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—lung cancer	0.000113	0.00023	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—lung cancer	0.000113	0.00023	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—lung cancer	0.000111	0.000224	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—lung cancer	0.00011	0.000224	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—lung cancer	0.00011	0.000224	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—lung cancer	0.00011	0.000224	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—lung cancer	0.00011	0.000223	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—lung cancer	0.00011	0.000223	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—lung cancer	0.00011	0.000222	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—lung cancer	0.00011	0.000222	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—lung cancer	0.000106	0.000215	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EP300—lung cancer	0.000105	0.000212	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EP300—lung cancer	0.000105	0.000212	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—lung cancer	0.000102	0.000207	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—lung cancer	0.000102	0.000206	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—lung cancer	0.000102	0.000206	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—lung cancer	9.9e-05	0.000201	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—lung cancer	9.9e-05	0.000201	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—lung cancer	9.8e-05	0.000199	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—lung cancer	9.8e-05	0.000199	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—lung cancer	9.78e-05	0.000198	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—lung cancer	9.78e-05	0.000198	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—lung cancer	9.78e-05	0.000198	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—lung cancer	9.77e-05	0.000198	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK3—lung cancer	9.36e-05	0.00019	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK3—lung cancer	9.36e-05	0.00019	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—lung cancer	9.11e-05	0.000185	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—lung cancer	9.11e-05	0.000185	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—lung cancer	9.02e-05	0.000183	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—lung cancer	8.91e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—lung cancer	8.91e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—lung cancer	8.42e-05	0.000171	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—lung cancer	8.42e-05	0.000171	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—lung cancer	7.73e-05	0.000157	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—lung cancer	7.73e-05	0.000157	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—lung cancer	7.48e-05	0.000152	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—lung cancer	7.48e-05	0.000152	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—lung cancer	7.15e-05	0.000145	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—lung cancer	7.15e-05	0.000145	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—lung cancer	6.85e-05	0.000139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—lung cancer	6.85e-05	0.000139	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—lung cancer	6.32e-05	0.000128	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—lung cancer	6.32e-05	0.000128	CbGpPWpGaD
